Profil
Sheila Singh is the founder of Empirica Therapeutics, Inc. She currently holds the position of Independent Director at Centre For Probe Development & Commercialization.
Aktive Positionen von Sheila Singh
| Unternehmen | Position | Beginn |
|---|---|---|
Empirica Therapeutics, Inc.
 Empirica Therapeutics, Inc. BiotechnologyHealth Technology Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada. | Vorstandsvorsitzender | - |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Direktor/Vorstandsmitglied | 17.06.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Empirica Therapeutics, Inc.
Empirica Therapeutics, Inc. BiotechnologyHealth Technology Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada. | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Health Technology |
